Breast scintigraphy with 99mTc-pertechnetate and 67Ga-citrate.
J Nucl Med
; 16(4): 293-9, 1975 Apr.
Article
de En
| MEDLINE
| ID: mdl-1113186
ABSTRACT
Radionuclide breast scintigraphy was evaluated as a noninvasive tumor-localizing modality. Technetium-99m-pertechnetate (99mTcO4) demonstrated good correlation between malignancy and postive scintigraphy (88% accuracy in 16 cases of breast carcinoma). The high false-positive rate (29% of proven benign breast disease) limits the use of 99mTcO4 as an aid to differential diagnosis. Gallium-67-citrate (67Ga) is limited as a diagnostic adjunct (localizing in only five of ten breast malignancies). Refined techniques of positioning, shielding, gamma camera imaging, and computer assistance have helped in visualizing abnormal radionuclide accumulation.
Recherche sur Google
Collection:
01-internacional
Base de données:
MEDLINE
Sujet principal:
Tumeurs du sein
/
Scintigraphie
/
Technétium
/
Gallium
Type d'étude:
Diagnostic_studies
Limites:
Adult
/
Female
/
Humans
/
Middle aged
Langue:
En
Journal:
J Nucl Med
Année:
1975
Type de document:
Article